| Model Number |
3010 |
| Medical Device Problem Codes |
Over-Sensing (1438); Inappropriate/Inadequate Shock/Stimulation (1574); Failure to Read Input Signal (1581)
|
| Health Effect - Clinical Code |
Shock from Patient Lead(s) (3162)
|
| Date of Event |
11/29/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
It was reported that this subcutaneous implantable cardioverter defibrillator (s-icd) exhibited oversensing, led to inappropriate electric shock.Evaluate the vector for programming was recommended.Currently, this product remains in service and no additional adverse patient effects were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
The product was already updated.This product remains in service and has not been returned to boston scientific, and as a result, laboratory analysis could not be conducted.With the available information, boston scientific concluded the clinical observation of oversensing is a known inherent risk of the product and is noted within the instructions for use (ifu), as well as the product's risk documentation.A review of the device history record (dhr) was performed.The review of the dhr identified that there were no process related non-conformances, scrap, or rework performed during the production that could explain the event.The reviews ensure each device meets specification prior to release for use.There is no indication the device manufacturing process contributed to the reported complaint.This device remains in service.As such, physical analysis has not been conducted in our laboratory.However, a labeling review and risk review were conducted.These reviews determined that the clinical observation of oversensing is a known inherent risk of the product.Review of labeling determined that the complaint situation was listed in the manual.There was no indication in the complaint that the product was not used in accordance with labeling.The manual was unlikely to be the cause of the reported complaint; translation, wording, or graphics does not require further review.This oversensing has been observed with this product previously and is a known inherent risk associated with its use and is documented in the labeling of this product.
|
| |
|
Event or Problem Description
|
|
It was reported that this subcutaneous implantable cardioverter defibrillator (s-icd) exhibited oversensing, led to inappropriate electric shock.Evaluate the vector for programming was recommended.Currently, this product remains in service and no additional adverse patient effects were reported.
|
| |
|
Search Alerts/Recalls
|